After four weeks of testimony and a full day of closing arguments, jurors will begin deliberating this morning to decide whether pharmaceutical giant Wyeth is responsible for the breast cancer suffered by three Northern Nevada women who took the company's hormone replacement drugs.
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week.
When Pamela Forrester went to her doctor in 1994 complaining of menopausal symptoms, hot flashes and trouble sleeping, she didn't think twice when he told her to start taking hormone replacement drugs, she testified today.
When Pamela Forrester went to her doctor in 1994 complaining of menopausal symptoms, hot flashes and trouble sleeping, she didn't think twice when he told her to start taking hormone replacement drugs, she testified Monday.
A doctor for one of the three women suing pharmaceutical giant Wyeth said a report issued a decade after he began prescribing the hormone-replacement drugs changed his mind about how he would recommend they be used.
A former salesman for pharmaceutical giant Wyeth testified that he was coached by the company to downplay studies showing its hormone replacement drug Prempro increased a woman's risk for breast cancer.
Three northern Nevada women are scheduled to go to trial this week against Wyeth Pharmaceuticals in the latest lawsuit claiming that the company's hormone replacement drugs cause breast cancer.
The picture is getting clearer about hormone therapy - but five years after a landmark study was halted, many questions are still unanswered.
When reports linked a remarkable decline in nationwide breast-cancer cases to falling numbers of women taking menopausal hormones, skeptics said it could just be that it was actually a drop in mammograms that meant fewer cancers were being detected.
A rapid decline in the use of hormone drugs in 2002 probably explains the drop in breast cancer cases in recent years, according to a University of California study.
